← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1195)
- Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains. (2023/03/01) ♡
- The many faces of globular glial tauopathy: A clinical and imaging study. (2023/02/01) ♡
- The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers. (2023/02/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effects of Palliative Care for Progressive Neurologic Diseases: A Systematic Review and Meta-Analysis. (2023/02/01) ♡
- Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders. (2023/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The effect of antidepressant therapy on a patient with progressive supranuclear palsy accompanied by depression, anxiety and fluctuating dementia. (2023/02/01) ♡
- Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson Syndrome. (2023/02/01) ♡
- Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy. (2023/01/23) ♡
- Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy. (2023/01/15) ♡
- Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies. (2023/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. (2023/01/01) ♡
- Performance of [(18)F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy. (2023/01/01) ♡
- Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms. (2023/01/01) ♡
- Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study. (2023/01/01) ♡
- microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes. (2023/01/01) ♡
- Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease. (2023/01/01) ♡
- rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy. (2023/01/01) ♡
- Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study. (2023/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes (2023-12-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP) (2023-12-01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients (2023-10-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Safety of Transcranial dIrect Current stiMulation (tDCS) in Progressive Supranuclear Palsy (PSP) (STIM-PSP) (2023-08-02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy (2023-07-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy (2023-06-26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients (2023-06-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders (2023-03-15) ♡
- Altered localization of nucleoporin 98 in primary tauopathies. (2022/12/22) ♡
- Differences in Striatal Metabolism in [(18)F]FDG PET in Parkinson's Disease and Atypical Parkinsonism. (2022/12/20) ♡
- Isolated Jaw and Tongue Tremor in a Definite Case of Progressive Supranuclear Palsy. (2022/12/20) ♡
- Hexameric Aggregation Nucleation Core Sequences and Diversity of Pathogenic Tau Strains. (2022/12/19) ♡
- Plasma sphingolipid abnormalities in neurodegenerative diseases. (2022/12/16) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. (2022/12/16) ♡
- Reflexive and volitional saccadic eye movements and their changes in age and progressive supranuclear palsy. (2022/12/15) ♡
- Rapidly Progressive Corticobasal Degeneration Mimicking Brainstem Encephalitis. (2022/12/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy: Case Study. (2022/12/12) ♡
- Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using (31)P-MRSI. (2022/12/12) ♡
- Changing faces of mitochondrial disease: autosomal recessive POLG disease mimicking myasthenia gravis and progressive supranuclear palsy. (2022/12/08) ♡
- Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation. (2022/12/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tau Isoforms: Gaining Insight into MAPT Alternative Splicing. (2022/12/06) ♡
- The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant. (2022/12/02) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Sporadic Creutzfeldt-Jakob disease as a mimic of progressive supranuclear palsy. (2022/12/01) ♡
- Differential cholinergic systems' changes in progressive supranuclear palsy versus Parkinson's disease: an exploratory analysis. (2022/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigation. (2022/12/01) ♡
- Bassoon contributes to tau-seed propagation and neurotoxicity. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular Imaging of the GABAergic System in Parkinson's Disease and Atypical Parkinsonisms. (2022/12/01) ♡
- Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy. (2022/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy. (2022/12/01) ♡
- CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. (2022/12/01) ♡
- An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with (18)F-PM-PBB3 ((18)F-APN-1607). (2022/12/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.